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Excessive alcohol consumption is one of the critical causative 
factors leading to alcoholic liver disease (ALD). ALD is char-
acterized by a wide spectrum of liver damage, ranging from 
simple uncomplicated liver steatosis (fatty liver) to steatohe-
patitis and liver fibrosis/cirrhosis. It has been believed that 
the obvious underlying cause for ALD is due to hepatocyte 
death induced by alcohol itself. However, recent sparkling 
studies have shown that diverse immune responses contrib-
ute to ALD because liver is enriched with numerous immune 
cells. Especially, a line of evidence has suggested that innate 
immune cells such as Kupffer cells and natural killer (NK)/ 
NKT cells are significantly involved in the pathogenesis of 
ALD via production of pro-inflammatory cytokines and other 
mediators. Indeed, more interestingly, hepatic stellate cells 
(HSCs), known as a major cell inducing liver steatosis and 
fibrosis, can be killed by liver NK cells, which could be sup-
pressed by chronic alcohol consumption. In this review, with 
the view of liver as predominant innate immune organ, we de-
scribe the pathogenesis of ALD in which what roles of innate 
immune cells are and how they are interacting with HSCs. 
[Immune Network 2010;10(6):181-187]
INTRODUCTION
Liver disease is one of major causes of morbidity and mortal-
ity worldwide and alcohol is one of the most prominent fac-
tors in liver disease (1,2). Alcoholic liver disease (ALD) en-
compasses a broad spectrum of diseases ranging from stea-
tosis  (fatty  liver),  steatohepatitis,  fibrosis,  cirrhosis  to  hep-
atocellular carcinoma (3,4). Of the ALD, steatosis is consid-
ered as mild condition, whereas steatohepatitis is pathogenic 
condition, which has a potential of progression to liver fib-
rosis, cirrhosis or hepatocellular carcinoma (5). Generally, the 
liver is composed of parenchymal cells (e.g. hepatocyte) and 
non-parenchymal  cells  such  as  sinusoidal  endothelial  cells, 
Kupffer cells, hepatic stellate cells (HSCs), dendritic cells and 
other lymphocytes. Interestingly, liver comprises enrichment 
of  innate  immune  cells  such  as  resident  macrophages 
(Kupffer  cells),  natural  killer  (NK),  NKT  and  γδ T  cells. 
(6-8). For example, mouse liver lymphocytes contain 10% NK 
cells, whereas rat and human liver lymphocytes contain about 
30%  to  50%  NK  cells.  NKT  cells  constitute  up  to  30%  and 
10% of the intrahepatic lymphocyte population in mice and 
human respectively (6,7,9). Interestingly, ALD has been con-
sidered as complex consequences of interaction among these 
cells, especially between hepatocytes and hepatic stellate cells 
or  innate  immune  cells  (3,4).  Previous  our  studies  demon-
strated  that  alcoholic  liver  steatosis  was  induced  by  HSC- 
mediated endocannabinoid and its hepatic CB1 receptor (10) 
and alcoholic liver fibrosis was accelerated due to abrogation 
of  antifibrotic  effects  of  NK  cells/interferon-γ  (IFN-γ) 
against HSCs (11). Other studies suggest that Kupffer cells are 
mainly  involved  in  alcohol-mediated  inflammation  via  lip-
opolysaccharide  (LPS)/toll  like  receptor  4  (TLR4)  signal-
ing-dependant mechanisms (4,12). Based on these evidences, 
researchers recognized the importance of innate immune re-
sponse in ALD. Therefore, in this review, we will focus and 
discuss about diverse involvements of HSCs and innate im-
munity  (Kupffer  cells/macrophages  and  NK  cells)  in  ALD Innate Immunity and Alcoholic Liver Disease
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such as alcoholic steatosis, steatohepatitis and liver fibrosis. 
ALCOHOLIC LIVER STEATOSIS (FATTY LIVER)
Alcoholic liver steatosis has been considered as a weak con-
dition for a long time. However, increasing evidence suggests 
that it seems to be a potentially pathologic state and it will 
progress more severe state in the presence of other co-factors 
such as sustained consumption of alcohol, hepatic virus in-
fection, diabetes or drugs (13,14). Fat accumulation in hep-
atocytes is the result of imbalanced fat metabolism such as 
decrease  mitochondrial  lipid  oxidation  but  enhanced  syn-
thesis of triglycerides. Several underlying mechanism of this 
have been suggested that it might be related with increased 
NADH/NAD＋ ratio (15,16), increased sterol regulatory ele-
ment-binding protein-1 (SREBP-1) activity (17,18), decreased 
peroxisome proliferator-activated receptor-α (PPAR-α) activ-
ity  (19,20)  and  decreased  AMP-activated  protein  kinase 
(AMPK)  activity  (10,18).
    In addition to pathological mechanisms for this, there are 
several interesting evidences that innate immune cells of liver 
are related in alcoholic liver steatosis (3,4,12,21,22). Kupffer 
cells  are  one  of  the  main  innate  immune  cells  involved  in 
steatotic  liver.  First,  alcohol  increased  gut  permeabilization, 
which allows more uptake of endotoxin/LPS in portal circu-
lation (21) and then Kupffer cells are activated in response 
to LPS via TLR4 signaling cascade, leading to produce several 
kinds  of  pro-inflammatory  cytokine  such  as  tumor  necrosis 
factor-α (TNF-α), interleukin (IL)-1, IL-6 and reactive oxy-
gen species (ROS) (3,4,22). Of these cytokines, contribution 
of TNF-α in developing alcoholic liver steatosis has been less 
characterized  compared  with  TNF-α-mediated  hepatic  in-
flammation.  However,  increased  expression  of  TNF-α has 
been  observed  in  alcoholic  liver  steatosis  of  mouse  (23,24) 
and absence of its receptor (TNF-α R1) activity inhibits the 
development of alcoholic liver steatosis (25,26). In addition, 
it has been reported that TNF-α has a potential to increase 
mRNA expression of SREBP-1c, a potent transcription factor 
of fat synthesis, in the liver of mice and to stimulate the matu-
ration of SREBP-1 in human hepatocytes, respectively (27,28). 
Furthermore, recent report showed that alcohol-mediated in-
filtration of macrophages decreased amounts of adiponectin 
(known as anti-steatosis peptide hormone) production of adi-
pocytes,  leading  to  alcoholic  liver  steatosis  (29).  Therefore, 
K u p f f e r  c e l l s / m a c r o p h a g e s  m a y  c o n t r i b u t e  t o  t h e  d e v e l o p -
ment of alcoholic liver steatosis by upregulating the SREBP1 
activity in hepatocytes and downregulating the production of 
adiponectin  in  adipocytes.  In  contrast,  IL-6  produced  by 
Kupffer cells may play a crucial role in protecting against al-
coholic liver steatosis via activation of signal transducer and 
activator of transcription 3 (STAT3), consequently inhibiting 
of  SREBP1  gene  expression  in  hepatocytes  (30-32).
  More interestingly, a recent our study reported that alco-
holic  liver  steatosis  was  mediated  mainly  through  activated 
HSCs-derived  endocannabinoid  and  its  receptor  (CB1R)  of 
hepatocytes (10). This study suggested that chronic alcohol 
drinking  activates  HSCs  to  produce  2-arachidonoylglycerol 
(2-AG),  one  of  endocannabinoid,  which  then  increased  the 
expression of SREPB1c and fatty acid synthase (FAS) but de-
creased  AMPK  activation,  consequently  leading  to  accumu-
lation of fat in hepatocyte. Another studies reported that acti-
vated HSC can be killed by liver NK cells through IFN-γ and 
tumor  necrosis  factor-related  apoptosis  inducing  ligand 
(TRAIL)-dependent manners (11,33-35). However, chronic al-
cohol consumption inhibited NK cytotoxicity against activated 
HSC,  leading  to  prolonged  survival  of  activated  HSC  (11).
ALCOHOLIC STEATOHEPATITIS (ASH)
Alcoholic steatohepatitis means united condition with fat ac-
cumulation  and  inflammation  in  the  liver  and  more  pro-
gressed  pathologic  state  compared  with  alcoholic  liver 
steatosis. In response to alcohol intake, innate immune cells 
initiate and maintain hepatic inflammation via pattern recog-
nition  receptors,  especially  TLRs  (36-38).
    Among activation of innate immune cells in liver, Kupffer 
cells have been identified as one of the significant elements 
in the pathogenesis of alcoholic steatohepatitis (22). Consider-
ing their specific location at the interface between the portal 
and the systemic circulation, Kupffer cells play a key role in 
orchestrating  the  immune  response  against  endotoxin/LPS. 
LPS, a component of gram-negative bacteria wall, has been 
considered to be a key molecule of activation in Kupffer cells, 
in which signals are transmitted through TLR4 (3,38-40). TLR4 
is a major component of the LPS recognition receptor com-
plex, which also involves the co-receptors CD14 and MD-2, 
and LPS binding protein (LBP) (41,42). LBP is a soluble shut-
tle protein that directly binds LPS and facilitates the associa-
tion between LPS and CD14 (43). Studies in knockout mouse 
models have shown that chronic alcohol feeding in mice defi-
cient of CD14, TLR4 and LPS-binding protein (LBP) results in 
alleviation  of  alcohol-induced  liver  injury  indicating  an  im-Innate Immunity and Alcoholic Liver Disease
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portant role for the TLR4 pathway (40,44,45). In addition, the 
importance  of  gut-derived  endotoxin/LPS  in  ALD  was  sug-
gested by experiments where treating the animals either with 
antibiotics  or  with  lactobacilli  to  remove  or  reduce  the  gut 
microflora provided protection from the features of ALD (46). 
T L R 4  i n i t i a t e s  t w o  m a j o r  p a t h w a y s .  A f t e r  b i n d i n g  L P S  w i t h  
TLR4,  recruited  TIR  domain-containing  adaptor  protein 
(TIRAP) and myeloid differentiation factor 88 (MyD88) lead 
to early-phase activation of nuclear factor-κB (NF-κB), pro-
ducing  pro-inflammatory  cytokines  including  TNF-α,  IL-6 
and  monocyte  chemotatic  protein-1  (MCP-1).  Meanwhile 
TIR-domain  containing  adaptor  inducing  IFN-β (TRIF)  and 
TRIF-related adaptor molecule (TRAM) activate interferon reg-
ulatory factor 3 (IRF3) leading to the production of type I IFN 
and  late  activation  of  NF-κB  (38,47).  However,  there  is  a 
recent  report  that  alcohol-mediated  liver  injury  and  in-
flammation  are  mainly  induced  by  TLR4-dependent  but 
MyD88-independent manners (48). Among pro-inflammatory 
cytokines, particularly TNF-α mainly contributes to the de-
velopment of ALD and its level is increased in patients with 
ASH (22) and in the liver of alcohol-fed animals (23,24). In 
addition, Kupffer cells secrete other important cytokines, in-
cluding IL-8, IL-12, and interferons, that contribute to the in-
trahepatic recruitment and activation of granulocytes that are 
characteristically found in severe ALD, influence immune sys-
tem polarization (49). Interestingly, TLR4 is expressed not on-
ly on innate immune cells such as Kupffer cells and recruited 
macrophages, but also on hepatocytes, sinusoidal endothelial 
cells and stellate cells in the liver (39). The role of TLR4 in 
these  cells  has  to  be  investigated.
    In  addition  to  LPS,  oxidative  stress-mediated  cellular  re-
s p o n s e s  a l s o  p l a y  a n  i m p o r t a n t  r o l e  i n  i n n a t e  i m m u n e  c e l l  
activation.  Kupffer  cells  are  also  a  major  source  of  ROS  in 
response to chronic alcohol exposure (50,51). One important 
ROS is the superoxide ion, which in activated phagocytes is 
mainly generated by the enzyme complex NADPH oxidase. 
Underscoring the important role of ROS in mediating ethanol 
damage,  treatment  with  antioxidants  and  deletion  of  the 
p47phox subunit of NADPH oxidase in ethanol-fed animals 
could reduce oxidative stress, activation of NF-κB, and TNF-
α release  in  Kupffer  cells,  thus,  preventing  liver  injury 
(50,52). In addition, NADPH oxidase induces TLR2 and TLR4 
expression in human monocytic cells (53). Furthermore, evi-
dence  shows  that  direct  interaction  of NADPH  oxidase  iso-
z y m e  4  w i t h  T L R 4  i s  i n v o l v e d  i n  L P S - m e d i a t e d  R O S  g e n -
eration  and  NF-κB  activation  in  neutrophils  (54).
ALCOHOLIC LIVER FIBROSIS
HSCs are known as a major cell type inducing liver fibrosis 
(55). Generally, HSCs are located in the Disse’s space as a 
quiescent status in normal healthy liver, but by liver injuries 
they become activated and differentiated into myofibroblastic 
c e l l s  t h a t  a r e  c h a r a c t e r i z e d  b y  a  l o s s  o f  v i t a m i n  A  ( r e t i n o l ) 
and enhanced extracellular matrix, especially collagen fibers, 
leading  to  liver  fibrosis.
    Interestingly,  recent  reports  suggest  that  innate  immune 
cells (Kupffer cells and NK/NKT cells) are closely involved 
in the liver fibrogenesis. First, Kupffer cells are generally con-
sidered as a positive regulator in liver fibrosis. Actually, in-
creasing evidences suggest that chronic alcohol consumption 
leads to liver fibrosis via the activation of the profibrogenic 
effects of Kupffer cells due to enhanced transport of endotox-
in/LPS  in  the  gut,  inducing  production  of  pro-inflammatory 
cytokines such as TNF-α, IL-6 and transforming growth fac-
tor-β (TGF-β) (3,14,23,24). Among these cytokines, TGF-β 
is  known  as  a  key  regulator  of  HSC  activation  and 
differentiation. Thus, it is believed that Kupffer cells positively 
regulate alcoholic liver fibrosis via TGF-β-mediated HSC acti-
vation and subsequently promote collagen synthesis of HSCs. 
In contrast, recent findings interestingly suggest the novel role 
of  NK  cells  having  anti-fibrotic  effects  via  multiple  mecha-
nisms (33-35,56,57). First, NK cells directly kill early activated 
HSCs in NKG2D- and TRAIL-dependent manners but not qui-
escent HSCs (35,56). This is because early activated HSCs ex-
press  NK  cell-activating  ligand  retinoic  acid  early  inducible 
gene 1 (RAE-1) via retinol metabolism and TRAIL receptors 
but  express  decreased  MHC-I,  NK  cell-inhibitory  ligand 
(33,57). Second, NK cells can suppress liver fibrosis via pro-
duction of IFN-γ, which induces HSC cell cycle arrest and 
apoptosis in STAT1-dependant manner (34,58). Analogous to 
NK cells, NKT cells (invariant NKT cells) can also suppress 
a c t i v a t i o n  o f  H S C s  v i a  d i r e c t  k i l l i n g  a n d  I F N -γ production 
(59). However, anti-fibrotic effects of NKT cells are beneficial 
only  at  early  stage  of  liver  fibrosis  because  of  their  quick 
depletion.
    Although the functions of hepatic NK/NKT cells are known 
a little in ALD, it is generally accepted now that chronic alco-
hol  consumption  accelerates  liver  fibrosis  due  to  the  sup-
pressed activity of NK cell in patients and mice and enhanced 
alcoholic liver injury as well (11,60-62). The activation status 
of NK cells has been reported to be decreased by alcohol, 
possibly  because of  increased IL-10  and  TGF-β release  by Innate Immunity and Alcoholic Liver Disease
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Figure 1. Involvement of innate 
immune cells and HSCs in alcoholic
liver disease (ALD).
monocytes and activated HSCs (11,63) In case of NKT cells, 
they seem to contribute to alcoholic liver injury since activa-
tion of NKT cell accelerates whereas NKT deficiency delays 
alcoholic liver injury (64,65). Nevertheless reports of alcohol 
effects  on  NK/NKT  cell  functions  are  still  controversial. 
Therefore,  further  investigation  is  needed  in  animal  and 
human.
CONCLUSIONS
The innate immune cells of liver play important roles in dan-
gerous stress such as alcoholic liver injuries and infection of 
microorganism.  Recently  a  line  of  evidences  has  demon-
strated that innate immune responses are closely connected 
with the development of ALD and we integrate these findings 
in Fig. 1. Especially, activation of Kupffer cells by alcohol ap-
pears to be required for the development of alcoholic steato-
hepatitis  via  LPS-TLR4  signaling  pathways.  However,  endo-
cannabinoid  production  (2-AG)  of  activated  HSCs  might  be 
another major factor for the induction of alcoholic steatosis. 
Therefore, we should simultaneously consider both types of 
cells  when  developing  therapeutics  for  alcoholic  steatohe-
patitis. For example, although we successfully inhibit activa-
tion of Kupffer cells by drugs activated HSCs still induce accu-
mulation of fat in the liver, leading to lipotoxicity and in turn 
to  generative  of  oxidative  stress  and  inflammation,  sub-
sequently  restoring  steatohepatitis.  More  interestingly,  al-
though the role of NKT in ALD is obscure, NK cells are re-
sponsible for anti-steatotic and anti-fibrotic functions via kill-
ing activated HSCs that may reduce production of 2-AG and 
collagen.  However,  functions  of  NK  cells  are  abrogated  or 
suppressed  by  chronic  alcohol  consumption  and  high  level 
of  TGF-β in  the  liver.  Therefore,  further  understanding  of 
the roles of innate immunity and HSCs help us to develop 
novel  therapeutic  targets  to  treat  ALD.
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